Chinese Biotech Startup Harbour BioMed Secures $102.8M In Series C Round – China Money Network

Chinese Biotech Startup Harbour BioMed Secures $102.8M In Series C Round – China Money Network

What to read around the web today

• Chinese biotech startup Harbour BioMed secures $102.8M in Series C round (China Money Network)
• Methotrexate-loaded tumour-cell-derived microvesicles can relieve biliary obstruction in patients with extrahepatic cholangiocarcinoma (Nature Biomedical Engineering)
• Ophthalmic drugs, cancer cell therapies attract $340M+ on two HKEX biotech debuts (Endpoints News)
• China's Sinovac Phase III trials in Brazil could take as little as three months (BioWorld)